Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity

More from the rxbrief desk

• 

  rxbrief deskoncnursingnews.com· 1d

  FDA Approves Amivantamab for Recurrent or Metastatic HNSCC | Oncology Nursing News

• 

  rxbrief deskabcnews.com· 1d

  8th measles-related death reported in Wisconsin: Health officials

• cnn.com

  rxbrief deskcnn.com· 1d

  Measles kills again!

• 

  rxbrief deskcdc.gov· 2d

  CDC Statement on Increases in Recent Animal Rabies Activity and Associated Human Exposures

• nbcchicago.com

  rxbrief desknbcchicago.com· 2d

  Thousands of bottles of blood pressure medication recalled by FDA

• 

  rxbrief deskcdc.gov· 3d

  Weekly US Influenza Surveillance Report: Key Updates for Week 42, ending October 24, 2026